tiprankstipranks
Trending News
More News >
Immunotech Biopharm Ltd (HK:6978)
:6978
Hong Kong Market

Immunotech Biopharm Ltd (6978) Financial Statements

Compare
1 Followers

Immunotech Biopharm Ltd Financial Overview

Immunotech Biopharm Ltd's market cap is currently HK$1.71B. The company's EPS TTM is HK$-0.248; its P/E ratio is -6.43; Immunotech Biopharm Ltd is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Operating Income¥ -198.78M¥ -230.55M¥ -273.93M¥ -344.86M¥ -347.25M
EBITDA¥ -148.68M¥ -178.83M¥ -231.11M¥ -324.33M¥ -333.99M
Net Income¥ -186.91M¥ -334.82M¥ -318.11M¥ -354.22M¥ -439.05M
Balance Sheet
Cash & Short-Term Investments¥ 57.49M¥ 176.97M¥ 79.46M¥ 353.34M¥ 845.39M
Total Assets¥ 564.04M¥ 846.28M¥ 879.44M¥ 1.10B¥ 1.21B
Total Debt¥ 384.56M¥ 784.01M¥ 149.81M¥ 111.05M¥ 51.06M
Net Debt¥ 337.60M¥ 731.85M¥ 91.36M¥ -242.29M¥ -794.33M
Total Liabilities¥ 580.50M¥ 675.39M¥ 373.07M¥ 274.51M¥ 81.38M
Stockholders' Equity¥ -13.30M¥ 173.62M¥ 508.44M¥ 822.26M¥ 1.13B
Cash Flow
Free Cash Flow¥ -153.81M¥ -186.17M¥ -277.49M¥ -435.89M¥ -339.34M
Operating Cash Flow¥ -125.74M¥ -163.63M¥ -180.92M¥ -254.65M¥ -263.67M
Investing Cash Flow¥ 141.10M¥ -116.60M¥ 23.38M¥ -328.21M¥ -204.07M
Financing Cash Flow¥ -20.59M¥ 273.92M¥ -36.06M¥ -11.00M¥ 1.05B
Currency in CNY

Immunotech Biopharm Ltd Earnings and Revenue History

Immunotech Biopharm Ltd Debt to Assets

Immunotech Biopharm Ltd Cash Flow

Immunotech Biopharm Ltd Forecast EPS vs Actual EPS